DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment	Digestive System Diseases, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, skin disorder	Recruiting	Phase 4	2025-11-13		NCT07158164

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Rutgers, The State University of New Jersey	154

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer Center Initiative	Newark	United States	1
Cooperman Barnabas Medical Center	Livingston	United States	64
Jack and Sheryl Morris Cancer Center	New Brunswick	United States	1
RWJBarnabas Health - Community Medical Center	Toms River	United States	9
RWJBarnabas Health - Robert Wood Johnson University Hospita	New Brunswick	United States	1
RWJBarnabas Health - Robert Wood Johnson University Hospital Somerset	Somerville	United States	2
RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton	Hamilton	United States	4
RWJBarnabas Health Clara Maas Medical Center	Belleville	United States	2
RWJBarnabas Health Jersey City Medical Center	Jersey City	United States	4
RWJBarnabas Health Newark Beth Israel Medical Center	Newark	United States	1
Trinitas Hospital and Comprehensive Cancer Center	Elizabeth	United States	5
University Hospital	Newark	United States	10